An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Hematologic Malignancies
Related studies linked through entity extraction aliases.
Aberrant Expression of CD56 in Patients With Hematologic Malignancies.
- Status
- RECRUITING
- Phase
- N/A
RD13-01 for Patients With r/r CD7+ T/NK Cell Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Impact of the Comprehensive Geriatric Assessment on the Quality of Life OF Elderly Patients
- Status
- UNKNOWN
- Phase
- N/A
Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation
- Status
- WITHDRAWN
- Phase
- N/A
Register of Blood Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- N/A
A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE2
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
- Status
- COMPLETED
- Phase
- N/A
Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
- Status
- COMPLETED
- Phase
- N/A
Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Status
- RECRUITING
- Phase
- PHASE3
GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
- Status
- TERMINATED
- Phase
- PHASE1
Exercise Capacity and Physical Activity Levels in Newly Diagnosed Hematologic Malignant Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1